METHOD AND SYSTEM TO MANAGE DIABETES USING MULTIPLE RISK INDICATORS FOR A PERSON WITH DIABETES

• US 20140030748A1
• Filed: 07/27/2012
• Published: 01/30/2014
• Est. Priority Date: 07/27/2012
• Status: Abandoned Application

• Current Assignee: Lifescan Incorporated (Duv Holding Corporation)
• Original Assignee: Lifescan Incorporated (Duv Holding Corporation)
• Inventors: SCHAIBLE, Thomas
• Application Number:
  US13/560,627
• Publication Number:
  US 20140030748A1
• Time in Patent Office: Days
• US Class Current: 435/14
• CPC Class Codes: G01N 33/48792 Data management, e.g. communication with processing unit for in vivo diagnostics A61B5/0002; transmission systems for measured values G08C
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment

Abstract

Described are methods and systems to annunciate to the patient of the components involved in each of the daily risk range based on the glucose measurements to assist the patient in identification of whether it is hypoglycemia or hyperglycemia are driving the daily risk range of the measured glucose values.

Claims

1. A system for management of diabetes of a subject, the system comprising:

at least one glucose monitor that is configured to measure a glucose concentration based on an enzymatic reaction with physiological fluid in a biosensor that provides an electrical signal representative of the glucose concentration; and

a controller in communication with at least one glucose monitor, the controller being configured to receive or transmit glucose levels measured by the glucose monitor over a predetermined time period from the at least one glucose monitor and pump for determination of an average daily risk range with a maximal hyperglycemic value and a maximal hypoglycemic value for each day in the predetermined time period; and

wherein the maximal hyperglycemic and hypoglycemic values are also annunciated in combination with the daily risk range for each day of the predetermined time period.

2. The system of claim 1, in which the controller is configured to determine the average-daily-risk-range (ADRR) and the maximal hyperglycemic value and maximal hypoglycemic value with the following equations and logical conditions:

3. The system of claim 2, in which the controller is configured to annunciate the maximal hyperglycemic and hypoglycemic values are also annunciated in combination with the daily risk range for each day of the average daily risk range in a visual display.

4. The system of claim 3, in which a number of glucose measurements must be at least 3 for each day for the determination of the average daily risk range and the maximal hyperglycemic and hypoglycemic values.

5. The system of claim 4, in which the time period comprises any number of days from about one day to about 120 days, or combinations thereof.

10. The method of claim 3, in which a number of glucose measurements must be at least 3 for each day for the determination of the average daily risk range and the maximal hyperglycemic and hypoglycemic values.

6. A method for management of diabetes of a user with at least a glucose monitor, biosensor, and a controller, the method comprising the steps of:

measuring with the glucose monitor and biosensor a plurality of glucose values in physiological fluid of a user;

storing the measured glucose values in a memory of at least one of the monitor and controller;

determining an average daily risk range from the glucose values of the storing step for each day of a predetermined time period;

calculating a maximal hyperglycemic value and a maximal hypoglycemic value from the stored glucose values for each day of the predetermined time period; and

annunciating the average daily risk range and the maximal hyperglycemic and hypoglycemic values for each day of the predetermined time period.

7. The method of claim 6, in which the calculating step comprises ascertaining the maximal hyperglycemic and hypoglycemic values for each day with the following equations and logical conditions:

ƒ

(BG)=γ

([ln(BG)]^α

−

β

);

r(BG)=10[ƒ

(BG)]²;

Let RL(BG)=R(BG) and if ƒ

(BG)<

0;

else RL(BG)=0

Let RH(BG)=R(BG) if ƒ

(BG)>

0;

else RH(BG)=0

LR=max (RL(BG))

HR=max (RH(BG))

LR comprises the Maximal Hypoglycemic for each day

HR comprises the Maximal Hyperglycemic value for each day

Daily Risk Range for each day is defined as DRR=LR+HR

where

α

=1.084 (1.026 if mmol/L);

β

=5.381 (1.861 if mmol/L) and

γ

=1.509 (1.794 if mmol/L).

8. The method of claim 7, in which the determining of the average daily risk range comprises calculating the average for each day with an equation of the form:

9. The method of claim 8, in which the annunciating comprises displaying the maximal hyperglycemic and hypoglycemic values in one Cartesian graph with one axis representing glucose values and the other axis representing the number of days and displaying the daily risk range for each day of the average daily risk range in another Cartesian graph with one axis representing a risk range from low, medium, high and the other axis representing the number of days.

11. The method of claim 8, in which the predetermined time period comprises any number of days from about one day to about 120 days, or combinations thereof.